These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4186530)

  • 1. [Suppression of thyroid gland function by prolonged use of HB 419].
    Stötter G; Szabo J; Köhler W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1436-9. PubMed ID: 4186530
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect and tolerance of HB 419 in out-patient treated diabetics].
    Bauer G; Kloppe W; Schubert PU
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1434-6. PubMed ID: 5394467
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thyroid gland function during treatment with thyroid].
    Gronbaek P; Hansen FM; Iversen M
    Ugeskr Laeger; 1970 Feb; 132(9):421-5. PubMed ID: 5446570
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract]   [Full Text] [Related]  

  • 6. [The development of sulfonylurea late resistance].
    Angeli I
    Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930
    [No Abstract]   [Full Text] [Related]  

  • 7. [The functional status of the thyroid gland in patients with diabetes mellitus and the nature of its change as a function of the type of therapy administered].
    Trusov VV; Belosludtsev IA
    Probl Endokrinol Gormonoter; 1966; 12(4):19-21. PubMed ID: 6002010
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical trial of glybenclamide (HB-419): a new oral hypoglycemic agent.
    Choudhry AS; Gomez E; McKendry JB
    Appl Ther; 1970 May; 12(5):28-9. PubMed ID: 4912481
    [No Abstract]   [Full Text] [Related]  

  • 9. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
    Belser F; Brögli H; Constam G; Zollikofer H
    Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with HB 419 (glybenclamide) in the ambulatory diabetes treatment].
    Stratmann FW
    Med Welt; 1969 Jun; 26():1489-92. PubMed ID: 5809503
    [No Abstract]   [Full Text] [Related]  

  • 12. [Variation in the function of the thyroid gland in the course of therapy with antitubercular agents in tuberculous patients].
    Zunić D; Cisić G; Dragović O; Stanković D
    Tuberkuloza; 1967; 19(5):661-3. PubMed ID: 5188491
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with sulfonylurea tolazamide in an out-patient clinic for diabetics].
    Kanzler G; Trenkner G; Rausch-Stroomann JB
    Arzneimittelforschung; 1968 Oct; 18(10):1345-8. PubMed ID: 5756166
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic problems in iodine storage defects of the thyroid gland].
    Dabels J; Sievers P; Pietsch P; Holldorf M; Schwartz KD
    Z Gesamte Inn Med; 1970 Apr; 25(8):347-51. PubMed ID: 5538108
    [No Abstract]   [Full Text] [Related]  

  • 15. [Suppression of the thyroid gland using l-triiodothyronine. Dependence on function, iodine uptake, size of the thyroid gland and age].
    Heinze HG; Pabst HW; Sonntag A
    Munch Med Wochenschr; 1968 Aug; 110(34):1875-84. PubMed ID: 5695744
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid antibodies and protein-binding of thyroxine in patients with and without thyrotoxicosis.
    Bános C; Takó J; Györgyi S; Juhász J; Sztraka I; Kapus I
    Endokrinologie; 1973 Jan; 61(1):32-6. PubMed ID: 4633897
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of measurements of liver activity in the course of thyroid gland function studies].
    Denisiewicz R
    Pol Przegl Radiol Med Nukl; 1970; 34(4):595-602. PubMed ID: 5476514
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acceleration of the elimination of radioactive iodine from the thyroid].
    Bondarchuk AK
    Med Radiol (Mosk); 1990 Jan; 35(1):51-2. PubMed ID: 1689801
    [No Abstract]   [Full Text] [Related]  

  • 19. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thyroid suppression during and after thyrostatic treatment of thyrotoxicosis].
    Lazanov B; Vurbanov V; Baleva R; Dimitrova Ia
    Vutr Boles; 1976; 15(5):60-6. PubMed ID: 1014612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.